6 September 2010
ABX Micros Case Study / ISLH
Haematology analyser supports fast decision making at POC
The use of point of care testing (POCT) to make rapid treatment decisions is helping to achieve greater efficiency and improve patient pathways. The ABX Micros ES60 haematology analyser provides a fast, laboratory standard full blood count, with a 3-part differential in a variety of POC settings.
A study has confirmed that the granulocyte count of this 3-part differential haematology analyser correlates well when compared to the neutrophil count of a 5-part differential analyser, in the absence of specific flagging. The neutrophil count is a key parameter in determining the treatment outcomes, with regards to chemotherapy, for both oncology and haematology patients, as well as for some other drug therapies.
